Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Identification of a long non-coding RNA regulator of liver carcinoma cell survival

Identification of a long non-coding RNA regulator of liver carcinoma cell survival

Thumbnail Image
Download
Name

s41419-021-03453-w.pdf

Description
Published version
Size

1.84 MB

Format

Unknown

Checksum (MD5)

4f2799cec0d069b828838d66c832b3a8

sword-2021-06-04T17:47:30.original.xml (130 B)
Original SWORD entry document
Author(s)
Rybakova, Yulia
•
Gonzalez, John T
•
Bogorad, Roman
•
Chauhan, Vikash P.
•
Dong, Yike L.
•
Whittaker, Charles A.
•
Zatsepin, Timofei
•
Koteliansky, Victor
•
Anderson, Daniel Griffith
Date Issued
2021
Journal
Cell Death and Disease
Publisher
Springer Science and Business Media LLC
Version
Final published version
Abstract
© 2021, The Author(s). Genomic studies have significantly improved our understanding of hepatocellular carcinoma (HCC) biology and have led to the discovery of multiple protein-coding genes driving hepatocarcinogenesis. In addition, these studies have identified thousands of new non-coding transcripts deregulated in HCC. We hypothesize that some of these transcripts may be involved in disease progression. Long non-coding RNAs are a large class of non-coding transcripts which participate in the regulation of virtually all cellular functions. However, a majority of lncRNAs remain dramatically understudied. Here, we applied a pooled shRNA-based screen to identify lncRNAs essential for HCC cell survival. We validated our screening results using RNAi, CRISPRi, and antisense oligonucleotides. We found a lncRNA, termed ASTILCS, that is critical for HCC cell growth and is overexpressed in tumors from HCC patients. We demonstrated that HCC cell death upon ASTILCS knockdown is associated with apoptosis induction and downregulation of a neighboring gene, protein tyrosine kinase 2 (PTK2), a crucial protein for HCC cell survival. Taken together, our study describes a new, non-coding RNA regulator of HCC.
MIT Department
Koch Institute for Integrative Cancer Research at MIT
Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
Massachusetts Institute of Technology. Department of Biology
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Chemical Engineering
Terms of Use
Creative Commons Attribution 4.0 International license
https://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/133329.2
DOI of Published Version
https://doi.org/10.1038/s41419-021-03453-w
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.